Nanjing RegeneCore Biotech Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Nanjing RegeneCore Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of RC1416 Injection in Asthma (NCT07403487) | Nanjing RegeneCore Biotech Co., Ltd. | 2026-03-10 |
| Phase II Study of RC1416 Injection in COPD (NCT07402551) | Nanjing RegeneCore Biotech Co., Ltd. | 2026-03-06 |
| This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile. (NCT06756451) | Nanjing RegeneCore Biotech Co., Ltd. | 2025-03-25 |
| A Phase Ib Study of RC1416 Injection (NCT06911866) | Nanjing RegeneCore Biotech Co., Ltd. | 2024-10-25 |
| A Phase I Study of RC1416 Injection (NCT06067490) | Nanjing RegeneCore Biotech Co., Ltd. | 2023-06-29 |
Track Nanjing RegeneCore Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.